Kodak Reports Fourth-Quarter and Full-Year 2025 Financial Results
Company Achieved Revenue Growth for the Quarter and the Full Year
Company Achieved Significant Full-Year Improvements in Gross Profit and Operational EBITDA
Year-End Cash Balance of
Fourth quarter 2025 highlights include:
-
Consolidated revenues of
$290 million , compared with$266 million for Q4 2024, an increase of$24 million or 9 percent-
Advanced Materials & Chemicals (AM&C) revenues were
$85 million , compared with$68 million for Q4 2024, an increase of$17 million or 25 percent -
Print revenues were
$195 million , compared with$187 million for Q4 2024, an increase of$8 million or 4 percent
-
Advanced Materials & Chemicals (AM&C) revenues were
-
Gross profit of
$67 million , compared with$51 million for Q4 2024, an increase of$16 million or 31 percent - Gross profit percentage of 23 percent, compared with 19 percent for Q4 2024, an increase of 4 percentage points
-
GAAP net loss of
$108 million , compared with net income of$26 million for Q4 2024, a decrease of$134 million -
Operational EBITDA of
$22 million , compared with$9 million for Q4 2024, an increase of$13 million or 144 percent
Full year 2025 highlights include:
-
Consolidated revenues of
$1.069 billion , compared with$1.043 billion for the full year 2024, an increase of$26 million or 2 percent-
AM&C revenues were
$316 million , compared with$271 million for the full year 2024, an increase of$45 million or 17 percent -
Print revenues were
$715 million , compared with$737 million for the full year 2024, a decrease of$22 million or 3 percent
-
AM&C revenues were
-
Gross profit of
$232 million , compared with$203 million for the full year 2024, an increase of$29 million or 14 percent - Gross profit percentage of 22 percent, compared with 19 percent for the prior year, an increase of 3 percentage points
-
GAAP net loss of
$128 million , compared with GAAP net income of$102 million for the full year 2024, a decrease of$230 million -
Operational EBITDA of
$62 million , compared with$26 million for the full year 2024, an increase of$36 million or 138 percent -
A year-end cash balance of
$337 million , compared with$201 million onDecember 31, 2024 , an increase of$136 million -
Cash flow from operations increased
$487 million for the full year 2025 compared to the full year 2024
“Kodak ended 2025 with a strong fourth quarter, which has created a foundation for growth in 2026,” said
For the full year ended
GAAP net loss was
Find the Q4/Full Year 2025 Shareholder Letter and infographic here.
Revenue and Operational EBITDA by Reportable Segment Q4 2025 vs. Q4 2024
|
(in millions) |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Q4 2025 Actuals |
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
195 |
|
|
$ |
85 |
|
|
$ |
7 |
|
|
$ |
287 |
|
|
Operational EBITDA * |
$ |
8 |
|
|
$ |
8 |
|
|
$ |
6 |
|
|
$ |
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Q4 2024 Actuals |
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
187 |
|
|
$ |
68 |
|
|
$ |
7 |
|
|
$ |
262 |
|
|
Operational EBITDA * |
$ |
1 |
|
|
$ |
2 |
|
|
$ |
6 |
|
|
$ |
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Q4 2025 vs. Q4 2024 Actuals
|
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
8 |
|
|
$ |
17 |
|
|
$ |
- |
|
|
$ |
25 |
|
|
Operational EBITDA * |
$ |
7 |
|
|
$ |
6 |
|
|
$ |
- |
|
|
$ |
13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Q4 2025 Actuals on constant currency ** vs. Q4 2024 Actuals
|
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
3 |
|
|
$ |
17 |
|
|
$ |
- |
|
|
$ |
20 |
|
|
Operational EBITDA * |
$ |
7 |
|
|
$ |
6 |
|
|
$ |
- |
|
|
$ |
13 |
|
Revenue and Operational EBITDA by Reportable Segment FY 2025 vs. FY 2024
|
(in millions) |
|
|
|
|
|
|
|
|
|
|
|
||||
|
FY 2025 Actuals |
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
715 |
|
|
$ |
316 |
|
|
$ |
23 |
|
|
$ |
1,054 |
|
|
Operational EBITDA * |
$ |
3 |
|
|
$ |
39 |
|
|
$ |
20 |
|
|
$ |
62 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
FY 2024 Actuals |
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
737 |
|
|
$ |
271 |
|
|
$ |
20 |
|
|
$ |
1,028 |
|
|
Operational EBITDA * |
$ |
(8 |
) |
|
$ |
17 |
|
|
$ |
17 |
|
|
$ |
26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
FY 2025 vs. FY 2024 Actuals
|
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
(22 |
) |
|
$ |
45 |
|
|
$ |
3 |
|
|
$ |
26 |
|
|
Operational EBITDA * |
$ |
11 |
|
|
$ |
22 |
|
|
$ |
3 |
|
|
$ |
36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
FY 2025 Actuals on constant currency ** vs. FY 2024 Actuals
|
|
|
|
Advanced Materials & Chemicals |
|
|
Brand |
|
|
Total |
|
||||
|
Revenue |
$ |
(32 |
) |
|
$ |
44 |
|
|
$ |
3 |
|
|
$ |
15 |
|
|
Operational EBITDA * |
$ |
11 |
|
|
$ |
21 |
|
|
$ |
3 |
|
|
$ |
35 |
|
* Total Operational EBITDA is a non-GAAP financial measure. The reconciliation between GAAP and non-GAAP measures is provided in Appendix A of this press release.
** The impact of foreign exchange represents the foreign exchange impact using average foreign exchange rates for the three or twelve months ended
About
Cautionary Statement Regarding Forward-Looking Statements
This press release includes “forward-looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning Kodak’s plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, liquidity, investments, financing needs and business trends and other information that is not historical information. When used in this press release, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “predicts,” “forecasts,” “strategy,” “continues,” “goals,” “targets” or future or conditional verbs, such as “will,” “should,” “could,” or “may,” and similar words and expressions, as well as statements that do not relate strictly to historical or current facts, are intended to identify forward-looking statements. All forward-looking statements, including management’s examination of historical operating trends and data, are based upon Kodak’s current expectations and assumptions. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results or outcomes, or timing of actual results or outcomes, to differ materially from historical results or those expressed in or implied by such forward-looking statements.
Important factors that could cause actual events, results or outcomes, or their timing, to differ materially from the forward-looking statements include, among others, the risks and uncertainties described in more detail in Kodak’s Annual Report on Form 10-K for the year ended
Future events and other factors may cause Kodak’s actual results or outcomes to differ materially from the forward-looking statements. All forward-looking statements attributable to
APPENDICES
In this fourth quarter and full year 2025 financial results news release, reference is made to the following non-GAAP financial measures:
- Operational EBITDA; and
- Revenues and Operational EBITDA on a constant currency basis.
The change in revenues and Operational EBITDA on a constant currency basis, as presented in this financial results news release, is calculated using average foreign exchange rates for the three or twelve months ended
Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”). Operational EBITDA represents the consolidated (loss) earnings from continuing operations excluding the provision for income taxes; non-service cost components of pension and other postemployment benefits income; depreciation and amortization expense; restructuring costs and other; stock-based compensation expense; consulting and other costs; idle costs; interest expense; loss on early extinguishment of debt; other operating expense (income); and other charges (income), net.
The following table reconciles the most directly comparable GAAP measure of Net (Loss) Income to Operational EBITDA for the three months ended
|
(in millions) |
Q4 2025 |
|
|
Q4 2024 |
|
|
$Change |
|
|
% Change |
|
||||
|
Net (Loss) Income |
$ |
(108 |
) |
|
$ |
26 |
|
|
$ |
(134 |
) |
|
|
(515 |
%) |
|
All other |
|
(1 |
) |
|
|
— |
|
|
|
(1 |
) |
|
|
|
|
|
Depreciation and amortization |
|
8 |
|
|
|
7 |
|
|
|
1 |
|
|
|
|
|
|
Restructuring costs and other |
|
9 |
|
|
|
2 |
|
|
|
7 |
|
|
|
|
|
|
Stock based compensation |
|
1 |
|
|
|
1 |
|
|
|
— |
|
|
|
|
|
|
Idle costs (2) |
|
2 |
|
|
|
1 |
|
|
|
1 |
|
|
|
|
|
|
Other operating expense, net (3) |
|
4 |
|
|
|
6 |
|
|
|
(2 |
) |
|
|
|
|
|
Interest expense (3) |
|
15 |
|
|
|
15 |
|
|
|
— |
|
|
|
|
|
|
Pension income excluding service cost component (3) |
|
(74 |
) |
|
|
(49 |
) |
|
|
(25 |
) |
|
|
|
|
|
Loss on early extinguishment of debt (3) |
|
7 |
|
|
|
— |
|
|
|
7 |
|
|
|
|
|
|
Other charges (income), net (3) |
|
150 |
|
|
|
(1 |
) |
|
|
151 |
|
|
|
|
|
|
Provision for income taxes (3) |
|
9 |
|
|
|
1 |
|
|
|
8 |
|
|
|
|
|
|
Operational EBITDA |
$ |
22 |
|
|
$ |
9 |
|
|
$ |
13 |
|
|
|
144 |
% |
The following table reconciles the most directly comparable GAAP measure of Net (Loss) Income to Operational EBITDA and Operational EBITDA on a constant currency basis for the twelve months ended
|
(in millions) |
FY 2025 |
|
|
FY 2024 |
|
|
$Change |
|
|
% Change |
|
||||
|
Net (Loss) Income |
$ |
(128 |
) |
|
$ |
102 |
|
|
$ |
(230 |
) |
|
|
(225 |
%) |
|
All other |
|
(2 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
|
|
|
Depreciation and amortization |
|
29 |
|
|
|
28 |
|
|
|
1 |
|
|
|
|
|
|
Restructuring costs and other |
|
21 |
|
|
|
8 |
|
|
|
13 |
|
|
|
|
|
|
Stock based compensation |
|
5 |
|
|
|
6 |
|
|
|
(1 |
) |
|
|
|
|
|
Consulting and other costs (1) |
|
— |
|
|
|
1 |
|
|
|
(1 |
) |
|
|
|
|
|
Idle costs (2) |
|
5 |
|
|
|
2 |
|
|
|
3 |
|
|
|
|
|
|
Other operating expense (income), net (3) |
|
4 |
|
|
|
(10 |
) |
|
|
14 |
|
|
|
|
|
|
Interest expense (3) |
|
62 |
|
|
|
59 |
|
|
|
3 |
|
|
|
|
|
|
Pension income excluding service cost component (3) |
|
(128 |
) |
|
|
(173 |
) |
|
|
45 |
|
|
|
|
|
|
Loss on early extinguishment of debt (3) |
|
7 |
|
|
|
— |
|
|
|
7 |
|
|
|
|
|
|
Other charges (income), net (3) |
|
171 |
|
|
|
(3 |
) |
|
|
174 |
|
|
|
|
|
|
Provision for income taxes (3) |
|
16 |
|
|
|
8 |
|
|
|
8 |
|
|
|
|
|
|
Operational EBITDA |
$ |
62 |
|
|
$ |
26 |
|
|
$ |
36 |
|
|
|
138 |
% |
|
Impact of foreign exchange (4) |
|
(1 |
) |
|
|
— |
|
|
|
(1 |
) |
|
|
|
|
|
Operational EBITDA on a constant currency basis |
$ |
61 |
|
|
$ |
26 |
|
|
$ |
35 |
|
|
|
135 |
% |
Footnote Explanations:
|
(1) |
|
Consulting and other costs are professional services and internal costs associated with corporate strategic initiatives and litigation. Consulting and other costs included |
|
(2) |
|
Consists of third-party costs such as security, maintenance, and utilities required to maintain land and buildings in certain locations not used in any |
|
(3) |
|
As reported in the Consolidated Statement of Operations. |
|
(4) |
|
The impact of foreign exchange is calculated by using average foreign exchange rates for the twelve months ended |
A. FINANCIAL STATEMENTS
|
|
||||||||
|
(in millions) |
|
Three Months Ended |
|
|||||
|
|
|
|
|
|||||
|
|
|
2025 |
|
|
2024 |
|
||
|
Revenues |
|
|
|
|
|
|
||
|
Sales |
|
$ |
252 |
|
|
$ |
228 |
|
|
Services |
|
|
38 |
|
|
|
38 |
|
|
Total net revenues |
|
|
290 |
|
|
|
266 |
|
|
Cost of revenues |
|
|
|
|
|
|
||
|
Sales |
|
|
198 |
|
|
|
186 |
|
|
Services |
|
|
25 |
|
|
|
29 |
|
|
Total cost of revenues |
|
|
223 |
|
|
|
215 |
|
|
Gross profit |
|
|
67 |
|
|
|
51 |
|
|
Selling, general and administrative expenses |
|
|
47 |
|
|
|
43 |
|
|
Research and development costs |
|
|
8 |
|
|
|
8 |
|
|
Restructuring costs and other |
|
|
9 |
|
|
|
2 |
|
|
Other operating expense, net |
|
|
4 |
|
|
|
6 |
|
|
Loss from continuing operations before interest expense,
|
|
|
(1 |
) |
|
|
(8 |
) |
|
Interest expense |
|
|
15 |
|
|
|
15 |
|
|
Pension income excluding service cost component |
|
|
(74 |
) |
|
|
(49 |
) |
|
Loss on early extinguishment of debt |
|
|
7 |
|
|
|
— |
|
|
Other charges (income), net |
|
|
150 |
|
|
|
(1 |
) |
|
(Loss) earnings from continuing operations before income taxes |
|
|
(99 |
) |
|
|
27 |
|
|
Provision for income taxes |
|
|
9 |
|
|
|
1 |
|
|
NET (LOSS) EARNINGS |
|
$ |
(108 |
) |
|
$ |
26 |
|
|
|
||||||||
|
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|||||
|
(in millions) |
|
2025 |
|
|
2024 |
|
||
|
|
|
|
|
|
|
|
||
|
Cash flows from operating activities: |
|
|
|
|
|
|
||
|
Net (loss) earnings |
|
$ |
(108 |
) |
|
$ |
26 |
|
|
Adjustments to reconcile to net cash provided by operating activities: |
|
|
|
|
|
|
||
|
Depreciation and amortization |
|
|
8 |
|
|
|
7 |
|
|
Pension and other postretirement income |
|
|
(1 |
) |
|
|
(44 |
) |
|
Gain on settlement of |
|
|
(66 |
) |
|
|
— |
|
|
Asset impairments |
|
|
3 |
|
|
|
4 |
|
|
Paid-in-kind interest expense |
|
|
— |
|
|
|
6 |
|
|
Stock based compensation |
|
|
1 |
|
|
|
1 |
|
|
Non-cash changes in workers' compensation and other employee benefit
|
|
|
(1 |
) |
|
|
(3 |
) |
|
Loss on early extinguishment of debt |
|
|
7 |
|
|
|
— |
|
|
Cash proceeds received from reversion of assets from |
|
|
618 |
|
|
|
— |
|
|
Provision (benefit) from deferred income taxes |
|
|
2 |
|
|
|
(1 |
) |
|
Increase in trade receivables |
|
|
— |
|
|
|
(1 |
) |
|
(Increase) decrease in miscellaneous receivables |
|
|
(1 |
) |
|
|
7 |
|
|
Decrease in inventories |
|
|
18 |
|
|
|
18 |
|
|
Decrease in trade accounts payable |
|
|
(1 |
) |
|
|
(2 |
) |
|
Increase (decrease) in liabilities excluding borrowings and trade payables |
|
|
11 |
|
|
|
(7 |
) |
|
Other items, net |
|
|
(1 |
) |
|
|
(7 |
) |
|
Total adjustments |
|
|
597 |
|
|
|
(22 |
) |
|
Net cash provided by operating activities |
|
|
489 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
||
|
Cash flows from investing activities: |
|
|
|
|
|
|
||
|
Additions to properties |
|
|
(6 |
) |
|
|
(17 |
) |
|
Net cash used in investing activities |
|
|
(6 |
) |
|
|
(17 |
) |
|
|
|
|
|
|
|
|
||
|
Cash flows from financing activities: |
|
|
|
|
|
|
||
|
Repayment of Amended and Restated Term Loan Agreement |
|
|
(306 |
) |
|
|
— |
|
|
Preferred stock cash dividend payments |
|
|
— |
|
|
|
(1 |
) |
|
|
|
|
(5 |
) |
|
|
— |
|
|
Finance lease payments |
|
|
— |
|
|
|
(1 |
) |
|
Net cash used in financing activities |
|
|
(311 |
) |
|
|
(2 |
) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
(1 |
) |
|
|
(6 |
) |
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
171 |
|
|
|
(21 |
) |
|
Cash, cash equivalents and restricted cash, beginning of period |
|
|
271 |
|
|
|
322 |
|
|
Cash, cash equivalents and restricted cash, end of period |
|
$ |
442 |
|
|
$ |
301 |
|
|
|
|
|
|
|
|
|
||
|
Non-cash investing item: |
|
|
|
|
|
|
||
|
Reversion of KRIP non-cash investment assets to |
|
$ |
148 |
|
|
|
— |
|
|
|
||||||||
|
(in millions, except per share data) |
|
Year Ended |
|
|||||
|
|
|
2025 |
|
|
2024 |
|
||
|
Revenues |
|
|
|
|
|
|
||
|
Sales |
|
$ |
917 |
|
|
$ |
882 |
|
|
Services |
|
|
152 |
|
|
|
161 |
|
|
Total net revenues |
|
|
1,069 |
|
|
|
1,043 |
|
|
Cost of revenues |
|
|
|
|
|
|
||
|
Sales |
|
|
730 |
|
|
|
720 |
|
|
Services |
|
|
107 |
|
|
|
120 |
|
|
Total cost of revenues |
|
|
837 |
|
|
|
840 |
|
|
Gross profit |
|
|
232 |
|
|
|
203 |
|
|
Selling, general and administrative expenses |
|
|
174 |
|
|
|
179 |
|
|
Research and development costs |
|
|
33 |
|
|
|
33 |
|
|
Restructuring costs and other |
|
|
21 |
|
|
|
8 |
|
|
Other operating expense (income), net |
|
|
4 |
|
|
|
(10 |
) |
|
Loss from continuing operations before interest expense,
|
|
|
— |
|
|
|
(7 |
) |
|
Interest expense |
|
|
62 |
|
|
|
59 |
|
|
Pension income excluding service cost component |
|
|
(128 |
) |
|
|
(173 |
) |
|
Loss on early extinguishment of debt |
|
|
7 |
|
|
|
— |
|
|
Other charges (income), net |
|
|
171 |
|
|
|
(3 |
) |
|
(Loss) earnings from continuing operations before income taxes |
|
|
(112 |
) |
|
|
110 |
|
|
Provision for income taxes |
|
|
16 |
|
|
|
8 |
|
|
NET (LOSS) EARNINGS |
|
$ |
(128 |
) |
|
$ |
102 |
|
|
|
|
|
|
|
|
|
||
|
Basic (loss) earnings per share attributable to |
|
$ |
(1.78 |
) |
|
$ |
0.97 |
|
|
|
|
|
|
|
|
|
||
|
Diluted (loss) earnings per share attributable to |
|
$ |
(1.78 |
) |
|
$ |
0.90 |
|
|
|
|
|
|
|
|
|
||
|
Number of common shares used in basic and diluted (loss) earnings per
|
|
|
|
|
|
|
||
|
Basic |
|
|
87.0 |
|
|
|
80.1 |
|
|
Diluted |
|
|
87.0 |
|
|
|
92.3 |
|
The notes accompanying the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended
|
|
||||||||
|
(in millions, except per share data) |
||||||||
|
|
|
As of |
|
|||||
|
|
|
2025 |
|
|
2024 |
|
||
|
ASSETS |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
337 |
|
|
$ |
201 |
|
|
Trade receivables, net of allowances of |
|
|
145 |
|
|
|
138 |
|
|
Inventories, net |
|
|
218 |
|
|
|
219 |
|
|
Other current assets |
|
|
141 |
|
|
|
37 |
|
|
Total current assets |
|
|
841 |
|
|
|
595 |
|
|
Property, plant and equipment, net |
|
|
191 |
|
|
|
189 |
|
|
|
|
|
12 |
|
|
|
12 |
|
|
Intangible assets, net |
|
|
17 |
|
|
|
20 |
|
|
Operating lease right-of-use assets |
|
|
37 |
|
|
|
27 |
|
|
Restricted cash |
|
|
96 |
|
|
|
92 |
|
|
Pension and other postretirement assets |
|
|
302 |
|
|
|
989 |
|
|
Other long-term assets |
|
|
121 |
|
|
|
77 |
|
|
TOTAL ASSETS |
|
$ |
1,617 |
|
|
$ |
2,001 |
|
|
|
|
|
|
|
|
|
||
|
LIABILITIES, REDEEMABLE, CONVERTIBLE PREFERRED STOCK AND EQUITY |
|
|
|
|
|
|
||
|
Accounts payable, trade |
|
$ |
101 |
|
|
$ |
120 |
|
|
Short-term borrowings and current portion of long-term debt |
|
|
1 |
|
|
|
1 |
|
|
Current portion of operating leases |
|
|
11 |
|
|
|
11 |
|
|
Other current liabilities |
|
|
155 |
|
|
|
129 |
|
|
Total current liabilities |
|
|
268 |
|
|
|
261 |
|
|
Long-term debt, net of current portion |
|
|
208 |
|
|
|
466 |
|
|
Pension and other postretirement liabilities |
|
|
191 |
|
|
|
197 |
|
|
Operating leases, net of current portion |
|
|
30 |
|
|
|
21 |
|
|
Other long-term liabilities |
|
|
207 |
|
|
|
197 |
|
|
Total liabilities |
|
|
904 |
|
|
|
1,142 |
|
|
|
|
|
|
|
|
|
||
|
Commitments and contingencies (Note 12) |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
Redeemable, convertible preferred stock, no par value, |
|
|
99 |
|
|
|
218 |
|
|
|
|
|
|
|
|
|
||
|
Equity |
|
|
|
|
|
|
||
|
Common stock, |
|
|
1 |
|
|
|
— |
|
|
Additional paid in capital |
|
|
1,278 |
|
|
|
1,150 |
|
|
|
|
|
(26 |
) |
|
|
(12 |
) |
|
Accumulated deficit |
|
|
(521 |
) |
|
|
(393 |
) |
|
Accumulated other comprehensive loss |
|
|
(118 |
) |
|
|
(104 |
) |
|
Total equity |
|
|
614 |
|
|
|
641 |
|
|
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY |
|
$ |
1,617 |
|
|
$ |
2,001 |
|
The notes accompanying the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended
|
|
||||||||
|
|
|
Year Ended |
|
|||||
|
(in millions) |
|
2025 |
|
|
2024 |
|
||
|
Cash flows from operating activities: |
|
|
|
|
|
|
||
|
Net (loss) earnings |
|
$ |
(128 |
) |
|
$ |
102 |
|
|
Adjustments to reconcile to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
||
|
Depreciation and amortization |
|
|
29 |
|
|
|
28 |
|
|
Pension and other postretirement income |
|
|
(43 |
) |
|
|
(155 |
) |
|
Gain on settlement of |
|
|
(66 |
) |
|
|
— |
|
|
Asset impairments |
|
|
24 |
|
|
|
4 |
|
|
Paid-in-kind interest expense |
|
|
36 |
|
|
|
23 |
|
|
Stock based compensation |
|
|
5 |
|
|
|
6 |
|
|
Non-cash changes in workers' compensation and other employee benefit
|
|
|
(1 |
) |
|
|
(2 |
) |
|
Net gain on sales of assets |
|
|
— |
|
|
|
(17 |
) |
|
Loss on early extinguishment of debt |
|
|
7 |
|
|
|
— |
|
|
Cash proceeds received from reversion of assets from |
|
|
618 |
|
|
|
— |
|
|
Provision (benefit) from deferred income taxes |
|
|
3 |
|
|
|
(1 |
) |
|
Decrease in trade receivables |
|
|
— |
|
|
|
51 |
|
|
Decrease in miscellaneous receivables |
|
|
1 |
|
|
|
1 |
|
|
Decrease (increase) in inventories |
|
|
6 |
|
|
|
(7 |
) |
|
Decrease in trade accounts payable |
|
|
(16 |
) |
|
|
(3 |
) |
|
Decrease in liabilities excluding borrowings and trade payables |
|
|
(11 |
) |
|
|
(46 |
) |
|
Other items, net |
|
|
16 |
|
|
|
9 |
|
|
Total adjustments |
|
|
608 |
|
|
|
(109 |
) |
|
Net cash provided by (used in) operating activities |
|
|
480 |
|
|
|
(7 |
) |
|
|
|
|
|
|
|
|
||
|
Cash flows from investing activities: |
|
|
|
|
|
|
||
|
Additions to properties |
|
|
(34 |
) |
|
|
(56 |
) |
|
Net proceeds from sales of assets |
|
|
5 |
|
|
|
17 |
|
|
Net cash used in investing activities |
|
|
(29 |
) |
|
|
(39 |
) |
|
|
|
|
|
|
|
|
||
|
Cash flows from financing activities: |
|
|
|
|
|
|
||
|
Net proceeds from ATM equity offering program |
|
|
1 |
|
|
|
— |
|
|
Repayment of Amended and Restated Term Loan Agreement |
|
|
(306 |
) |
|
|
(17 |
) |
|
Preferred stock cash dividend payments |
|
|
(2 |
) |
|
|
(4 |
) |
|
|
|
|
(7 |
) |
|
|
(1 |
) |
|
Finance lease payments |
|
|
— |
|
|
|
(1 |
) |
|
Net cash used in financing activities |
|
|
(314 |
) |
|
|
(23 |
) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
4 |
|
|
|
(7 |
) |
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
141 |
|
|
|
(76 |
) |
|
Cash, cash equivalents and restricted cash, beginning of period |
|
|
301 |
|
|
|
377 |
|
|
Cash, cash equivalents and restricted cash, end of period |
|
$ |
442 |
|
|
$ |
301 |
|
|
|
|
|
|
|
|
|
||
|
Non-cash investing and financing items: |
|
|
|
|
|
|
||
|
Non-cash investing activities: |
|
|
|
|
|
|
||
|
Reversion of KRIP non-cash investment assets to |
|
$ |
148 |
|
|
$ |
— |
|
|
Non-cash financing activities: |
|
|
|
|
|
|
||
|
Series C preferred stock exchange to common stock |
|
$ |
124 |
|
|
$ |
— |
|
The notes accompanying the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20260312377142/en/
Media Contact:
Investor Contact:
Source: